Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xenetic Biosciences, Inc. XBIO

Full chart Compare
Set alert

Price alert · XBIO

All alert types
1.87 USD -0.02 (-1.02%)

At closeNov 6, 2026, 4:00 PM EST

1.97 +0.10 +5.31%

After hours · Nov 6, 4:00 PM ET

1.76 Day range 1.97
1.72 52-week range 4.67
YTD
-13.79%
1 year
-31.22%

Financial health

Altman Z-Score

-37.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.4×
FY 2016: -0.6×FY 2017: -4.6×FY 2018: -2.0×FY 2019: -0.3×FY 2020: -1.2×FY 2021: -2.4×FY 2022: -0.6×FY 2023: -1.3×FY 2024: -1.6×FY 2025: -1.4×
FY 2016 5y median -1.4× FY 2025
P/S 1.2×
FY 2016: 10.7×FY 2017: 2.2×FY 2018: 0.0×FY 2019: 241×FY 2020: 29.8×FY 2021: 11.4×FY 2022: 2.4×FY 2023: 2.1×FY 2024: 2.5×FY 2025: 1.2×
FY 2016 5y median 2.4× FY 2025
P/B 0.5×
FY 2016: 2.0×FY 2017: 1.2×FY 2018: 1.5×FY 2019: 0.2×FY 2020: 1.1×FY 2021: 0.7×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 1.0×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
P/FCF -1.6×
FY 2016: -3.6×FY 2017: 11.2×FY 2018: -2.3×FY 2019: -0.6×FY 2020: -3.1×FY 2021: -2.8×FY 2022: -0.8×FY 2023: -1.3×FY 2024: -2.2×FY 2025: -1.6×
FY 2016 5y median -1.6× FY 2025
EV/EBITDA 1.6×
FY 2016: -0.5×FY 2017: -3.1×FY 2018: -2.0×FY 2019: 0.7×FY 2020: -0.3×FY 2021: 0.9×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 0.0×FY 2025: 1.6×
FY 2016 5y median 0.9× FY 2025
EV/Sales -1.4×
FY 2016: 9.3×FY 2017: 1.5×FY 2018: 0.0×FY 2019: -366×FY 2020: 3.6×FY 2021: -4.3×FY 2022: -5.3×FY 2023: -1.5×FY 2024: -0.0×FY 2025: -1.4×
FY 2016 5y median -1.5× FY 2025
FCF Yield -61.9%
FY 2016: -27.6%FY 2017: 8.9%FY 2018: -43.5%FY 2019: -155.8%FY 2020: -32.7%FY 2021: -35.7%FY 2022: -127.0%FY 2023: -78.0%FY 2024: -45.8%FY 2025: -61.9%
FY 2016 5y median -61.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 98.8%FY 2017: 97.9%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -95.2%
FY 2016: -1581.0%FY 2017: -47.1%FY 2018: 0.0%FY 2019: -75511.7%FY 2020: -3189.8%FY 2021: -495.1%FY 2022: -393.6%FY 2023: -177.8%FY 2024: -168.2%FY 2025: -95.2%
FY 2016 5y median -177.8% FY 2025
Net Margin -90.1%
FY 2016: -1806.9%FY 2017: -47.4%FY 2018: 0.0%FY 2019: -74856.6%FY 2020: -2493.1%FY 2021: -486.4%FY 2022: -383.9%FY 2023: -162.8%FY 2024: -158.4%FY 2025: -90.1%
FY 2016 5y median -162.8% FY 2025
ROE -36.2%
FY 2016: -335.2%FY 2017: -25.1%FY 2018: -73.6%FY 2019: -74.2%FY 2020: -89.2%FY 2021: -30.7%FY 2022: -48.0%FY 2023: -42.2%FY 2024: -65.9%FY 2025: -36.2%
FY 2016 5y median -42.2% FY 2025
ROIC -38.3%
FY 2016: -248.2%FY 2017: -20.7%FY 2018: -56.7%FY 2019: -63.9%FY 2020: -89.5%FY 2021: -31.2%FY 2022: -49.2%FY 2023: -46.1%FY 2024: -70.0%FY 2025: -38.3%
FY 2016 5y median -46.1% FY 2025
ROA -32.1%
FY 2016: -258.4%FY 2017: -18.8%FY 2018: -50.6%FY 2019: -59.3%FY 2020: -82.7%FY 2021: -28.5%FY 2022: -44.5%FY 2023: -39.0%FY 2024: -57.4%FY 2025: -32.1%
FY 2016 5y median -39.0% FY 2025

Growth (YoY)

Revenue 19.0%
FY 2016: 0.0%FY 2017: 152.8%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 2460.3%FY 2021: 165.6%FY 2022: 47.1%FY 2023: 48.8%FY 2024: -1.6%FY 2025: 19.0%
FY 2016 FY 2025
Operating Income 32.6%
FY 2016: -382.9%FY 2017: 92.5%FY 2018: -103.9%FY 2019: -77.1%FY 2020: -8.2%FY 2021: 58.8%FY 2022: -16.9%FY 2023: 32.8%FY 2024: 6.9%FY 2025: 32.6%
FY 2016 FY 2025
EPS (diluted) 38.5%
FY 2016: -146.4%FY 2017: 94.3%FY 2018: -94.0%FY 2019: 42.1%FY 2020: 69.5%FY 2021: 68.4%FY 2022: 16.7%FY 2023: 39.6%FY 2024: 5.2%FY 2025: 38.5%
FY 2016 FY 2025
Free Cash Flow 18.8%
FY 2016: -66.0%FY 2017: 116.9%FY 2018: -535.3%FY 2019: 1.0%FY 2020: 33.3%FY 2021: -11.0%FY 2022: -8.6%FY 2023: 20.1%FY 2024: 31.5%FY 2025: 18.8%
FY 2016 FY 2025

Financial Health

Current Ratio 8.3×
FY 2016: 4.5×FY 2017: 3.0×FY 2018: 0.7×FY 2019: 7.8×FY 2020: 13.2×FY 2021: 13.2×FY 2022: 12.7×FY 2023: 11.8×FY 2024: 7.4×FY 2025: 8.3×
FY 2016 5y median 11.8× FY 2025
Quick Ratio 8.3×
FY 2016: 4.5×FY 2017: 3.0×FY 2018: 0.7×FY 2019: 7.8×FY 2020: 13.2×FY 2021: 13.2×FY 2022: 12.7×FY 2023: 11.8×FY 2024: 7.4×FY 2025: 8.3×
FY 2016 5y median 11.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.9×
FY 2016: 0.1×FY 2017: 1.6×FY 2018: 0.1×FY 2019: 1.1×FY 2020: 2.5×FY 2021: 3.2×FY 2022: 2.0×FY 2023: 2.2×FY 2024: 1.6×FY 2025: 2.9×
FY 2016 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2016: -65.0×FY 2017: -1963×FY 2018: -302×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31